Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dianhydrogalactitol is a hexitol epoxide DNA alkylating agent that has been found in P. caesiopruinosa.1,2 It induces N7-alkylation of guanine and interstrand DNA cross-links in vitro.1 Dianhydrogalactitol (0.5-8 µM) halts the cell cycle at the G2/M phase in U-251MG and T98G glioblastoma cells.3 It decreases the migration and invasion of U251 glioblastoma cells and tube formation of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 12.5 µg/ml.4 Dianhydrogalactitol (2.5 mg/kg) increases survival in a U-251MG mouse xenograft model when administered in combination with the alkylating agent prodrug temozolomide (Item No. 14163).3
WARNING This product is not for human or veterinary use.
1. Alkylation by 1,2:5,6-
2. Insights into in vitro phenotypic plasticity, growth and secondary metabolites of the mycobiont isolated from the lichen Platygramme caesiopruinosa. Arch. Microbiol. 204(1), 90 (2021).
3. Dianhydrogalactitol overcomes multiple temozolomide resistance mechanisms in glioblastoma. Mol. Cancer Ther. 20(6), 1029-1038 (2021).
4. Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis. Biomed. Pharmacother. 91, 1065-1074 (2017).